ALLORIN Allopurinol 300mg tablet

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

allopurinol, Quantity: 300 mg

Available from:

Medis Pharma Pty Ltd

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: lactose monohydrate; maize starch; povidone; magnesium stearate

Administration route:

Oral

Units in package:

60 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Indications: Main clinical manifestations of urate/uric acid deposition. These are gouty arthritis, skin tophi and/or renal involvement through crystal deposition or stone formation. Such clinical manifestations may occur in: idiopathic gout; uric acid nephropathy; neoplastic disease and myeloproliferative disease with high cell turnover rates, in which high urate levels occur either spontaneously or after cytotoxic therapy; certain enzyme disorders which lead to overproduction of urate and involve hypoxanthine guanine phosphoribosyltransferase including Lesch-Nyhan syndrome, glucose-6- phosphatase including glycogen storage disease, phosphoribosylpyrophosphate synthetase, phosphoribosylpyrophosphate amidotransferase. Allorin is indicated for the management of 2, 8-dihydroxyadenine (2,8-DHA) renal stones related to deficient activity of adenine phosphoribosyl transferase. Allorin is indicated for the management of recurrent mixed calcium oxalate renal stones in the presence of hyperuricosuria, when fluid, dietary and similar measures have failed.

Product summary:

Visual Identification: A round flat bevel-edged tablet, white, with a breakline on one face, diameter 11.00mm.; Container Type: Blister Pack; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

1994-10-11

Patient Information leaflet

_Consumer Medicine Information _
_ALLORIN™ (allopurinol) _
_ _
_ _
_ _
_Ref: CMI - 103-3_
ALLORIN™ Tablets
CONSUMER MEDICINE INFORMATION
_allopurinol 100 mg & 300 mg tablets_
_WHAT IS IN THIS LEAFLET _
This leaflet answers some of the common
questions about ALLORIN Tablets
_._
It does not
contain all the available information. It does not
take the place of talking to your doctor or
pharmacist.
All medicines have risks and benefits. Your
doctor has weighed the risks of you taking
ALLORIN Tablets against the benefits they
expect it will have for you.
If you have any concerns about taking this
medicine, ask your doctor or pharmacist.
Keep this leaflet with the medicine. You may
need to read it again.
_WHAT ALLORIN TABLETS ARE USED FOR _
ALLORIN
tablets
contain
allopurinol
(pronounced al-oh-PURE-i-nole).
ALLORIN Tablets are used to prevent gout and
gouty arthritis. They are not used to treat an
acute attack of gout.
Gout and gouty arthritis are caused by too much
uric acid in the blood. This excess uric acid may
form deposits of uric acid crystals in various
joints, producing red, hot, swollen and very
painful
and
tender
joints.
The
joint
most
commonly affected is the base of the big toe,
but the elbow, knee, hand, foot, ankle, arm or
shoulder may also be effected.
ALLORIN
Tablets
work
by
reducing
the
production
of
uric
acid
in
the
body,
and
therefore help prevent the formation of deposits
of uric acid crystals.
ALLORIN Tablets are also used to prevent or
treat other medical problems that may occur if
too much uric acid is present in the body. These
include certain kinds of kidney stones or other
kidney problems.
ALLORIN Tablets are also used for certain
enzyme disorders and in some types of cancers
where the body produces too much uric acid.
ALLORIN is also used to lower high uric acid
levels caused by some anticancer medicines.
Your doctor may have prescribed ALLORIN
Tablets for another reason. Ask your doctor if
you have any questions about why ALLORIN
Tablets have been prescribed for you.
There is no evidence